biz.yahoo.com
Business Wire
NOTICE ISSUED BY INTERNATIONAL TRADE
COMMISSION BUSINESS EDITORS,
HEALTH/MEDICAL WRITERS
SANTA CLARA, Calif.--(BW HealthWire)--March 6, 2000--VISX,
INCORPORATED (NASDAQ: VISX.O) today announced that the United States
International Trade Commission (ITC) has issued a Notice of its
decision in the investigation of the activities of Nidek Co. Ltd. and
its United States subsidiaries. The Commission adopted portions of the
Initial Determination of the ITC issued in December 1999, ruling that
Nidek and its United States subsidiaries have not violated Section 337
of the Tariff Act of 1930, as amended on the basis that the Nidek
laser system does not infringe the VISX's United States Patent No.
5,711,762 and that VISX does not practice that patent. With regard to
the validity and enforceability of the patent, the Commission did not
affirm the Initial Determination and took no position.
The Commission did not review the findings of the ITC
administrative law judge with respect to VISX's U.S. Patent Number
4,718,418. That ruling upholding the enforceability of the `418 Patent
but finding that it was not infringed by the Nidek System is therefore
final.
The Commission's determination is subject to review by the United
States Court of Appeals for the Federal Circuit and VISX may appeal
all or a portion of the decision.
VISX is a worldwide leader in the development of refractive laser
technology. VISX systems are commercially available in the United
States and markets worldwide.
--30--ap/sf*
CONTACT: VISX Inc.
Lola Wood, 877/463-6847
ir@visx.com
visx.com
KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: MEDICAL DEVICES
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com
Copyright 2000, Business Wire
What's next? Long on VISX. Good Luck to all. |
